Alessandro Specchia

Dr. Alessandro Specchia

Ospedale Valduce, Como, Lombardy, Italy

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
Domenico RomeoDomenico Romeo
Domenico Romeo
ASAlessandro Specchia
Alessandro Specchia
FSFrancesca Sini
Francesca Sini
SBSarah Bompard
Sarah Bompard
APAlessia Di Polito
Alessia Di Polito
EMEugenio Mercuri
Eugenio Mercuri

14 July 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Domenico RomeoDomenico Romeo
Domenico Romeo
ASAlessandro Specchia
Alessandro Specchia
Alfonso FasanoAlfonso Fasano
Alfonso Fasano
CLchiara leoni
chiara leoni
RORoberta Onesimo
Roberta Onesimo
GZGiuseppe Zampino
Giuseppe Zampino
Costello syndrome (CS), a rare syndrome with multisystemic involvement inherited as a dominant trait, is characterized by developmental delay, coarse facial appearance, cardiac defects including hypertrophic cardiomyopathy, skin abnormalities, brain complications, and a predisposition to certain malignancies. The musculoskeletal system is particularly affected in CS, with peculiar orthopedic anomalies that impact posture and gait. Dystonia has been recently documented to contribute to abnormal postures and musculoskeletal anomalies characterizing CS, suggesting the possible use of pharmacological treatments to treat these complications. We report the case of a child affected by CS displaying a particularly severe musculoskeletal involvement with dystonic posture especially in the arms and legs. The Movement Disorder-Childhood Rating Scale (MD-CRS) and a gait analysis were used to assess clinical patterns of hyperkinetic movement disorder and dystonia. The child was further treated with trihexyphenidyl for six months with a final dosage of 14 mg. MD-CRS and gait analysis assessments provided evidence for a significant improvement of posture and the related musculoskeletal problems with no side effects. Our preliminary study report provides first evidence that pharmacological anti-dystonia treatment significantly improves movement and posture disorders in patients with CS. Further studies enrolling larger cohorts of patients should be performed to validate these preliminary observations.

18 May 2023 in IEEE Open Journal of Engineering in Medicine and Biology
Verified
Journal Article
Open access
IMIsabella Martinelli
Isabella Martinelli
SKStéphanie Konik
Stéphanie Konik
EGEleonora Guanziroli
Eleonora Guanziroli
JTJoseph Tharayil
Joseph Tharayil
CFCarolina Foglia
Carolina Foglia
MBMichela Bassolino
Michela Bassolino
Objective: Human figure drawings are widely used in clinical practice as a qualitative indication of Body Representations (BRs) alterations in stroke patients. The objective of this study is to present and validate the use of a new app called QDraw for the quantitative analysis of drawings and to investigate whether this analysis can reveal distortions of BRs in chronic stroke patients. Results: QDraw has proven to generate reliable data as compared to manual scoring and in terms of inter-rater reliability, as shown by the high correlation coefficients. Moreover, human figure drawings from chronic stroke patients demonstrated a distortion of upper limb perception, as shown by a significantly higher arm length asymmetry compared to legs, whereas no difference was found in healthy controls. Conclusions: The present study supports the use of quantitative, digital methods (the QDraw app) to analyze human figure drawings as a tool to evaluate BRs distortions in stroke patients.

30 March 2022 in Toxins
Verified
Journal Article
Open access
PDF file
CPcristina m del prete
cristina m del prete
MVMattia Giuseppe Viva
Mattia Giuseppe Viva
STStefania De Trane
Stefania De Trane
Fabrizio BrindisinoFabrizio Brindisino
Fabrizio Brindisino
Giovanni BarassiGiovanni Barassi
Giovanni Barassi
Raffaello PellegrinoRaffaello Pellegrino
Raffaello Pellegrino
The motor behaviour of patients with Upper Motor Neuron Syndrome (UMNS) is characterised by spasticity. The first-line treatment for this clinical condition is Botulinum neurotoxin A (BoNTA), but the number and key locations of muscles which need to be treated is not much discussed in the literature. Cross-sectional analysis of outpatient cohort with UMNS spasticity, who were potential candidates for BoNTA treatment, was performed. Between November 2020 and November 2021, all consecutive adult patients eligible for BoNTA treatment were enrolled. The inclusion criteria encompass UMNS spasticity (onset being ≥6 months), with disabling muscles hypertonia. Patients underwent a clinical evaluation, a comprehensive assessment with the Modified Ashworth Scale, with the Modified Rankin Scale, and a patients’ perception-centred questionnaire. In total, 68 participants were enrolled in the study, among them 40 (58.8%) were male; mean age 57.9 ± 15.1. In women, BoNTA was more frequently required for adductor group muscles, independently from potential confounders (OR = 7.03, 95%CI: 1.90–25.97). According to the pattern of disability, patients with hemiparesis more frequently need to be treated in the upper limb, whereas the diplegia/double-hemiparesis group needed to be treated more frequently at the adductor and crux muscles compared to their counterparts. UMNS spasticity in women could require more attention to be paid to the treatment of adductor muscle spasticity, potentially because the dysfunction of those muscles could influence sphincteric management, required for perineal hygiene and/or sexual life.

31 August 2024
Verified
Book Chapter
Closed access
PDF file
FMFranco Molteni
Franco Molteni
ARAlessandro Robustelli
Alessandro Robustelli
RPRachele Penati
Rachele Penati
GCGiovanni Cannaviello
Giovanni Cannaviello
ASAlessandro Specchia
Alessandro Specchia
EGEleonora Guanziroli
Eleonora Guanziroli

5 February 2026 in Applied Sciences
Verified
Journal Article
Open access
PDF file
ASAlessandro Scano
Alessandro Scano
CBCristina Brambilla
Cristina Brambilla
EGEleonora Guanziroli
Eleonora Guanziroli
Valentina LanzaniValentina Lanzani
Valentina Lanzani
NMNicol Moscatellli
Nicol Moscatellli
FMFranco Molteni
Franco Molteni
Stroke frequently results in persistent upper limb impairments, which are often accompanied by compensatory movement strategies that are not fully captured by conventional clinical assessment scales. Quantitative kinematic analyses may provide more objective and sensitive measures of motor dysfunction. In this study, we propose a probabilistic, distribution-based analysis of upper limb kinematics to quantify motor disability in post-stroke patients. We analyzed reaching movement data acquired with a markerless Kinect V2 system from 36 post-stroke patients and age-matched healthy controls. Wrist velocity profiles were characterized using distribution metrics, including variance, skewness, kurtosis, and entropy, and divergence measures (Hellinger distance, Kullback–Leibler divergence, and Jensen–Shannon divergence). Group differences between patients and controls, as well as across impairment levels stratified by the Fugl-Meyer (FM) score, were evaluated. Several distribution metrics significantly discriminated patients from controls and scaled with motor impairment severity. In particular, divergence-based measures showed a strong association with FM scores, indicating increasing deviation from normative movement patterns with greater impairment. These findings demonstrate that distribution-based metrics focusing on kinematic analysis provide a clinically meaningful, objective descriptor of motor dysfunction and complement conventional biomechanical assessments, offering a sensitive framework for quantifying motor disability after stroke.